These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4975781)

  • 21. [Hepatic function in subjects treated with estro-progestinic drugs].
    Scalzerle V; Laudanna Sclazerle A
    Minerva Ginecol; 1968 Feb; 20(4):371-4. PubMed ID: 5738735
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes of unspecific immune parameters (CH50E, C3, C4, C3A, lysozyme, CRP at the end of 2-year use of a synthetic sex steroid drug].
    Stelzner A; Klinger G; Süsse I; Kittlick M; Süss J
    Dtsch Gesundheitsw; 1978; 33(29):1381-5. PubMed ID: 668505
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progestogens and lactation. Preliminary note].
    García Herrera E; Gaitán Díaz Leal F
    Medicina (Mex); 1965 Jul; 45(967):309-20. PubMed ID: 5893040
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacologic study of the quingestanol-ethinyl estradiol combination].
    Eben-Moussi E; Van den Driessche J
    Rev Fr Gynecol Obstet; 1971 Apr; 66(4):283-5. PubMed ID: 5104265
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral contraceptives and serum-proteins.
    Elstein M
    Lancet; 1970 Feb; 1(7642):367. PubMed ID: 4189633
    [No Abstract]   [Full Text] [Related]  

  • 27. [Luteolytic agents and reproduction].
    Cortés-Gallegos V
    Gac Med Mex; 1973 Oct; 106(4):259-86. PubMed ID: 4593968
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical trial of oral contraceptive agent, Combiquens].
    Welti H
    Ther Umsch; 1973 Jul; 30(7):543-9. PubMed ID: 4578456
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of the progestin-estrogen oral contraceptives on blood serum copper, copper oxidase, magnesium and sulphur concentrations.
    de Jorge FB; Canato C; Medici C; Delascio D
    Matern Infanc (Sao Paulo); 1967; 26(3):261-7. PubMed ID: 5603640
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum protein alterations produced in women by synthetic estrogens.
    Musa BU; Doe RP; Seal US
    J Clin Endocrinol Metab; 1967 Oct; 27(10):1463-9. PubMed ID: 4167507
    [No Abstract]   [Full Text] [Related]  

  • 31. Wy 3707, a totally synthesized progestogen for contraception.
    Roland M
    Int J Fertil; 1966; 11(4):401-4. PubMed ID: 5970362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The appearance of pregnancy typical proteins during the use of hormonal contraceptives].
    Straube W; Göretzlehner G; Hofmann R; Klausch B
    Zentralbl Gynakol; 1973 Sep; 95(36):1281-6. PubMed ID: 4203325
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of oral contraceptives on serum protein concentrations.
    Mendenhall HW
    Surg Forum; 1969; 20():404-5. PubMed ID: 5383101
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influence of ovulation inhibitors on endocrine parameters].
    Bottermann P
    Internist (Berl); 1972 Jul; 13(7):293-7. PubMed ID: 4559270
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of oestrogens and progestogens on serum protein levels.
    Horne CH; Mallinson AC; Goudie RB
    J Clin Pathol; 1970 May; 23(4):378. PubMed ID: 5430430
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serum protein values following an attack of infectious mononucleosis (author's transl)].
    Svejda J; Richter J; Král V
    Cas Lek Cesk; 1979 Jan; 118(2):53-5. PubMed ID: 427850
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of the effect of ethinyl estradiol and mestranol. Clinical data from the literature].
    Pellegrini R; Seassaro E
    Quad Clin Ostet Ginecol; 1969 Sep; 24(9):597-617. PubMed ID: 4926507
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical adverse effects and biochemical changes due to ovulation inhibitors].
    Clavadetscher P; Weber H
    Schweiz Med Wochenschr; 1973 Feb; 103(7):231-7. PubMed ID: 4686758
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutrophil alkaline phosphatase activity. Effect of certain oral contraceptive hormones.
    Macaraeg PV; Connell E; Bianchine JR
    Arch Intern Med; 1968 Nov; 122(5):412-6. PubMed ID: 4176910
    [No Abstract]   [Full Text] [Related]  

  • 40. [A new estrogen variant in the oral contraceptive Non-Ovlon].
    Sarembe B
    Dtsch Gesundheitsw; 1973; 28(5):223-7. PubMed ID: 4579102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.